SPIA
NUVB icon

Steward Partners Investment Advisory’s Nuvation Bio NUVB Stock Holding History

Steward Partners Investment Advisory’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,500
Closed -$12K – 4113
2024
Q4 		$12K Buy
+4,500
New +$11.6K ﹤0.01% 3024
2021
Q4 		– Sell
-100
Closed -$1K – 3273
2021
Q3 		$1K Hold
100
– – ﹤0.01% 3092
2021
Q2 		$1K Buy
+100
New +$1.14K ﹤0.01% 6979

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Steward Partners Investment Advisory's NUVB Position: Q1 2025 in Review

Steward Partners Investment Advisory sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 4,500 shares — an estimated $12K sold.

Steward Partners Investment Advisory first reported a position in NUVB in Q2 2021 and held it in 3 quarters. The position peaked at $12K in Q4 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Steward Partners Investment Advisory reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 4,500 Nuvation Bio shares in Q1 2025, an estimated $12K.
  • Steward Partners Investment Advisory first reported a position in Nuvation Bio in Q2 2021 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Nuvation Bio position peaked at $12K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2025, filed 13 May 2025.